Skip to main content
Clinical Trials/DRKS00011674
DRKS00011674
Completed
Not Applicable

Impact of intestinal microbiome on infections, course and outcome of haematological-oncological patients treated with chemotherapy - MicroIntest

niversitätsklinikum Magdeburg0 sites12 target enrollmentFebruary 3, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
gut microbiome
Sponsor
niversitätsklinikum Magdeburg
Enrollment
12
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2017
End Date
July 12, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Magdeburg

Eligibility Criteria

Inclusion Criteria

  • 1\.Age \=18 years;
  • 2\.Written informed consent;
  • 3\.AML first diagnose;
  • 4\.Therapy with repetitive chemotherapy cycles, inclusive allogeneic or autologous stem cell transplantation

Exclusion Criteria

  • 1\.Antibiotic therapy \=4 weeks before study inclusion;
  • 2\.AML teatment with cytoreductive long\-term therapy (e. g. hydroxyurea);
  • 3\.Stool transplantation (e. g. due to relapsed C. difficile infection)

Outcomes

Primary Outcomes

Not specified

Similar Trials